Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus
UMass Medical School and Massachusetts General Hospital are the first to safely treat two research participants with a synthetic microRNA, delivered into the spinal fluid, designed to silence a human disease-causing gene. Details of the treatment appear in the New England Journal of Medicine.
Read more